Amer Joseph

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy”.

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney International Reports(2021)10.1016/j.ekir.2021.10.008

N/A

4.8DataRank · unranked

165 citations

Gerasimos Filippatos, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope +10 more

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Hypertension(2022)10.1161/hypertensionaha.122.19744

N/A

2.1DataRank · unranked

98 citations

Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing +8 more

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

Clinical Kidney Journal(2022)10.1093/ckj/sfac234

N/A

2.0DataRank · unranked

102 citations

Bertram Pitt, Biff F. Palmer, Csaba P. Kövesdy, Ellen Burgess, Gerasimos Filippatos +12 more

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Nephrology Dialysis Transplantation(2021)10.1093/ndt/gfab336

N/A

1.7DataRank · unranked

62 citations

Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luís M. Ruilope +12 more

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

European Heart Journal - Cardiovascular Pharmacotherapy(2023)10.1093/ehjcvp/pvad001

N/A

1.3DataRank · unranked

39 citations

Stefan D. Anker, Phyllis August, Andrew J.S. Coats, James L. Januzzi, Boris Mankovsky +13 more

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care(2022)10.2337/dc21-1944

N/A

1.2DataRank · unranked

35 citations

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt +92 more

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

JAMA Cardiology(2023)10.1001/jamacardio.2023.1505

N/A

0DataRank · unranked

35 citations

Bertram Pitt, Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Luís M. Ruilope +10 more

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European Heart Journal(2021)10.1093/eurheartj/ehab777

N/A

0DataRank · unranked

1207 citations

Gerasimos Filippatos, Bertram Pitt, Stefan D. Anker, Peter Rossing, Amer Joseph +7 more

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Kidney International(2020)10.1016/j.kint.2020.07.013

N/A

0DataRank · unranked

119 citations

Rajiv Agarwal, William G. Herrington, Hiddo J.L. Heerspink, Johannes F.E. Mann, Shahnaz Shahinfar +76 more